Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

Lili Jiang(Dalian Medical University), Enhua Wang(China Medical University), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Qingfu Zhang(Duke University), Siyang Zhang(China Medical University), Xueshan Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jihong Chang(China Medical University)
BMC Cancer
June 22, 2010
10.1186/1471-2407-10-318
Cited by 221

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362
Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer
|Cancer Science|2010|340